Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iman Imanirad

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
NPJ Digital Medicine|April 4, 2026
Comparison of AI-generated radiology impressions: a multi-stakeholder evaluationSharang Phadke, Nivedita Suresh, Zachary Allen, et al.
Cancers|November 9, 2024
Correction: Nelson et al. <i>UGT1A1</i> Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. <i>Cancers</i> 2021, <i>13</i>, 1566Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, et al.
Cancers|April 3, 2021
<i>UGT1A1</i> Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical ImplementationRyan S Nelson, Nathan D Seligson, Sal Bottiglieri, et al.
Cancer Medicine|July 1, 2021
The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract datasetAmina Dhahri, Jori Kaplan, Syeda M H Naqvi, et al.
The Oncologist|March 11, 2022
BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal CancerElaine Tan, Junmin Whiting, Hao Xie, et al.
Journal of Medical Imaging and Radiation Oncology|May 10, 2020
CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort studyZhigang Yuan, Marissa Frazer, Geoffrey G Zhang, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
British Journal of Cancer|September 7, 2024
TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trialPatrick M Boland, Sarbajit Mukherjee, Iman Imanirad, et al.
Future Oncology (London, England)|July 21, 2020
Modeling precision genomic-based radiation dose response in rectal cancerZhigang Yuan, Marissa Frazer, Kamran A Ahmed, et al.
American Journal of Clinical Oncology|March 23, 2022
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI CancersElaine Tan, Junmin Whiting, Todd Knepper, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
NPJ Digital Medicine|April 4, 2026
Comparison of AI-generated radiology impressions: a multi-stakeholder evaluationSharang Phadke, Nivedita Suresh, Zachary Allen, et al.
Cancers|November 9, 2024
Correction: Nelson et al. <i>UGT1A1</i> Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. <i>Cancers</i> 2021, <i>13</i>, 1566Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, et al.
Cancers|April 3, 2021
<i>UGT1A1</i> Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical ImplementationRyan S Nelson, Nathan D Seligson, Sal Bottiglieri, et al.
Cancer Medicine|July 1, 2021
The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract datasetAmina Dhahri, Jori Kaplan, Syeda M H Naqvi, et al.
The Oncologist|March 11, 2022
BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal CancerElaine Tan, Junmin Whiting, Hao Xie, et al.
Journal of Medical Imaging and Radiation Oncology|May 10, 2020
CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort studyZhigang Yuan, Marissa Frazer, Geoffrey G Zhang, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
British Journal of Cancer|September 7, 2024
TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trialPatrick M Boland, Sarbajit Mukherjee, Iman Imanirad, et al.
Future Oncology (London, England)|July 21, 2020
Modeling precision genomic-based radiation dose response in rectal cancerZhigang Yuan, Marissa Frazer, Kamran A Ahmed, et al.
American Journal of Clinical Oncology|March 23, 2022
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI CancersElaine Tan, Junmin Whiting, Todd Knepper, et al.
Pageof 4